ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000784.1|O-antigen_2 # 241 # 525 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.625	BGC0000784.1|O-antigen_2 	241	525	+	Loose	550	23.0978	LRA-19	26.98	3002513	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGACCAAGTCGGAGTTGATCGAACGGATCGTTACCCATCAGGGGCAACTGTCCGCGAAGGATGTCGAGTTGGCAATCAAGACCATGCTGGAGCAAATGTCCCAGGCCCTGGCGACCGGGGACCGGATCGAGATCCGTGGCTTCGGCAGCTTTTCCTTGCACTACCGCGCCCCGCGCGTCGGTCGCAACCCCAAGACCGGGGAGTCGGTACGCCTCGACGGCAAGTTCGTGCCGCACTTCAAGCCGGGCAAGGAGTTGCGGGATCGGGTCAACGAGCCGGAGTGA	MTKSELIERIVTHQGQLSAKDVELAIKTMLEQMSQALATGDRIEIRGFGSFSLHYRAPRVGRNPKTGESVRLDGKFVPHFKPGKELRDRVNEPE	MNSEMSQTSFKIRILVTCLLSIAQLTMAQQVQVTEPPITNQDWVKPYPPFRIVGNLYYVGTYDLACYLIVTPQGNILINTGLASSAPMIEASIKALGFKFSDTKILLTTQAHYDHVGAMAAIKKSTNAQLMIDEKDSPVMADGGSSDYELFGSTGSTYEPVKADRLLKNGDKITLGGTTLVMLHHPGHTKGSCSFLFDVKDESKSYKVLIANMPSIITSKKFSDIPTYPGIAEDYTYTFDAMKKVHFDIWLSSHASQFGMHSKHKPGEAYNPGVFIDRAGYDKAVGDLEDKFSKKKQADK	31.33	gnl|BL_ORD_ID|1339|hsp_num:0	1462			342	531	
BGC0000784.1|O-antigen_3 # 522 # 869 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.486	BGC0000784.1|O-antigen_3 	522	869	+	Loose	1000	23.8682	HelR	31.15	3007208	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	helicase-like RNA polymerase protection protein	GTGATATCGGTCCATTCGGATATTGGAGTCTTCATGCTTTGGATAAGGCGCATACTGCTGATGGGTGGAGTGCTGTTTATCGCTCTTCTCGTAGTAGTTATGGTATTGGAAAACCGGCAGGTTACTCATTTCGAACTGTTCGGTTTGCTTACCCCCGAGCTGCCCGTTGTTCTCTATGTTGCCTTGGTGTTCATCTTGGGTGGTTTCATTGGCCTATTGGCCGGTTCATCACTTTTAGCGCGAGCTAATATACGTATCAAGGCAATCGAGAAGGATCTTGCCAAGGCTCGGAAAGAGAGAGATTCCTTACTTGCTCGGCTTTCTTCATCGAGTGATGGGGGGGGCTGA	MISVHSDIGVFMLWIRRILLMGGVLFIALLVVVMVLENRQVTHFELFGLLTPELPVVLYVALVFILGGFIGLLAGSSLLARANIRIKAIEKDLAKARKERDSLLARLSSSSDGGG	MRVLSSVDQLDGTSAFDLPDRLSAKTDPALIAADERHFSAIAKSLAETITELSDRLDATRKAPGGVGREAMDRDAEIHRLTGRLRTLRRFGLDLCLGRIVTADDAEPVYVGRLGLTDSTGRRLLVDWRSPAAEPFFAATHADPMGLTSRRRYRWTGGRVSDYWDEVFTADGLEEHAALDDQSAFIASLGSSRSPQMRDVLATIQADQDAIIRAGSRGTLVVDGGPGTGKTVVALHRSAHLLYADPRLGHRRGGVLFVGPHQPYLAYVADVLPSLGEEGVRTCTVRDLVAEGAGAAVERDAEVARLKSSADMVRAIEAAVRFYEEPPTQRMTVSTDWADVRLTADDWAEAFDAPEAGTPHNEAREQIWEELGSILLGKLGDEVPEEEFRRALRQDEELAGALHGAWPLLEAADLVGDLWSVPAYLRKCAPWLDREDVAKLQRADAQAWTVSDLPLLDAARQRLGDPEAARRRRRQQATVAAERARMADVIADVLAADDDGEGAVTMLRGQDLKDTLVDEAALTGVEPDLLAGPFAHIVVDEAQELSDAEWQMLLLRCPSRSFTIVGDRAQARHGFTESWEERLARVGLDRITVASLSINYRTPEEVMAEAEPAIRAALPDANVPTSVRSSGVPVLRGPVEELDTIVDEWLAANADGTACVIGAPRFRPGPRVRSLTPSLSKGLEFDLVVLVDPEDFGGGIEGAVDRYVAMTRATKQLVILTSS	15.93	gnl|BL_ORD_ID|4837|hsp_num:0	5819			774	930	rifampin; rifaximin; rifabutin
BGC0000784.1|O-antigen_4 # 1284 # 2321 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.495	BGC0000784.1|O-antigen_4 	1284	2321	+	Loose	1900	31.5722	MuxB	30.3	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTAGCGTTGAAAGAAGAAAAAAACGGTGGCGGTGAAATTGATCTCGTAAGACTTTTTCAGATTCTATGGAAGGGAAAGTGGATTATCCTGGTCGTAGCTCTTATATTTGGCATTGTTGCTGCTATATATGCCTATACAAGTAAGCCGGTTTATGAAGCCAGTATCGCCGTGTTGCCACCCTCGCTGAGCAATGTTGCCGGTTTTAACCAGGGGCGTACCAAGGAGTCGGGTCTTCAGGCATTTAAAGTTCAGGATGTCTATTCCGTGTTCTTGCGCAATCTTCAAGCTGATGAGACTCGGCACCGCTTCTTCGAGAATGTCTACTTGCCGTCGCTAGGAGGTGAGAGGCCGGCGTCGCGCGATAGTCTCTATAGGGTATTTAATGAAAAGATCAGTATTACTCTGCCAGACAAGACCCAGCCGAGTCGCTATCGGCTAACAGTAGAACAGGAAGATCCTGAGCTGGCCGCTGAGTGGATCCGTCGCTATCTTGCCGATACGGCCGAACATTCCGTCCAAGAAATGGTTAAGAATGCGCACCGTGAGATAGAGGTCAAGGCTCGGGATGTCGATCAGCGGATCCAAACGCTACGTGAAACTGCTAAGTTACGCCGTGAAGATAGAATTGTGCAACTTAGAGAGGCTCTAAAAGTCGCGGATGCTGTGGGGTTGGAAAAGCCTCCGATGATAAGTGGGCAGGTATCTGAGCAGCTTTCGGCTATCATGAACGGTAGCTTGATGTATATGCGGGGCAGCAAGGCGCTTAGAGGAGAGATCGAGGCTTTGGAAAGTCGTGTGTCAGATGATCCTTTCATCCCTGCTTTACGAACTCTGCAGGAGCAGGAAAAACTCTATAGTAGTTTACGGGTAAACACCGACGAGGTTGCTGTGTTCCGTCAGGATGGTTCGGTTGAGACGCCCGATTCTCCCGTGAAGCCGAAGAAGCTTTTACTCGTCATGATGGGGTTGTTGCTCGGTGGTGCGGTTGGTGTCGTGACTGTCGTGTTTAATTCGCTCTATCGCAATAAGCGGTAA	MVALKEEKNGGGEIDLVRLFQILWKGKWIILVVALIFGIVAAIYAYTSKPVYEASIAVLPPSLSNVAGFNQGRTKESGLQAFKVQDVYSVFLRNLQADETRHRFFENVYLPSLGGERPASRDSLYRVFNEKISITLPDKTQPSRYRLTVEQEDPELAAEWIRRYLADTAEHSVQEMVKNAHREIEVKARDVDQRIQTLRETAKLRREDRIVQLREALKVADAVGLEKPPMISGQVSEQLSAIMNGSLMYMRGSKALRGEIEALESRVSDDPFIPALRTLQEQEKLYSSLRVNTDEVAVFRQDGSVETPDSPVKPKKLLLVMMGLLLGGAVGVVTVVFNSLYRNKR	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	33.08	gnl|BL_ORD_ID|2364|hsp_num:0	2718			1962	2061	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000784.1|O-antigen_6 # 2982 # 4295 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.469	BGC0000784.1|O-antigen_6 	2982	4295	+	Loose	700	70.0922	ugd	24.0	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGAAAACCTGAGAGAAAAAGTTACTAGAAAGTTCAAGGATAAAGAGGCTCTTGTCGGGATCGTGGGGTTGGGCTATGTCGGACTCCCGCTTATGTTGCGTTATAATTCAATCGGTTTTAGAGTGCTTGGCATTGATATCGACGCCGAAAAAGTTAGAAGGCTGAATTCCGGTGAAAGCTATATTGAGCATATATCCGCGGAAAGCATTTCTCACGCTTGCTCTTCTGGTTTTGAAGCTACGACCGATTTCTCTCGGGCAAAAGAGTGCGACGCACTTATTCTTTGTGTTCCGACCCCGCTGAATAAATATCGCGAGCCGGATATGAGTTTTGTGGTTAATACTACGGAAGCTATTAAGCCGTATCTGCGTGAAGGACAAGTCGTCTCTCTTGAAAGCACAACCTATCCAGGTACCACTGAGGAGGAGCTGCTACCCAGGGTTCAGTCCGATGGGCTGGTCGTTGGGAAAAGTATATTTCTAGTCTATTCGCCAGAGCGTGAAGATCCAGGTAATCCGAATTTTGAAACCCGCACTATTCCAAAGGTAATTGGGGGGCATACCCCGGAATGCCTGGAAGTTGGAGTCGCTCTTTACGAACAGGCTATAGATAAAGTAGTTCCAGTGAGCTCTACCAAAGCTGCGGAAATGACCAAATTGCTGGAAAATATTCATCGCGCGGTGAATATCGGCCTGGTCAATGAGATGAAAGTAGTCGCGGACCGAATGGGTATCGATATTTTTGAAGTGGTAGATGCTGCAGCGACCAAACCTTTTGGATTTACCCCTTATTATCCAGGGCCTGGTTTGGGAGGGCACTGTATTCCCATCGATCCTTTCTACCTGACCTGGAAAGCACGCGAATATGGCTTGCATACTCGCTTCATCGAACTTTCTGGTGAAGTCAACAAGGCTATGCCGGAGTATGTAGTCAGTAAGCTAATGGATGGGCTGAATGAAAGAGGTAAGGCTCTTAAAGGCAGTCGCGTCTTGGTACTGGGTATTGCCTATAAGAAAAACGTAGATGATATGCGTGAGTCTCCTTCGGTTGAAATCATGGAACTGATTCAGGCCAAAGGAGGCATTGTCTCTTATAGCGATCCCCATGTTCCCAGTTTCCCCAAAATGCGTGAGCATCACTTTGACCTTGCTAGTGAGCCTCTGACTGCCGAAAGGCTTTCTCGTTTCGATGCGGTTGTGTTAGCAACTGATCATGATCGGTTTGATTACGATCTTATCCATGCTCACGCCAGCTTGGTTGTAGATAGTCGTGGAAAATATCGGGCGCCATCGCAGAAGGTAATCAAAGCCTGA	MENLREKVTRKFKDKEALVGIVGLGYVGLPLMLRYNSIGFRVLGIDIDAEKVRRLNSGESYIEHISAESISHACSSGFEATTDFSRAKECDALILCVPTPLNKYREPDMSFVVNTTEAIKPYLREGQVVSLESTTYPGTTEEELLPRVQSDGLVVGKSIFLVYSPEREDPGNPNFETRTIPKVIGGHTPECLEVGVALYEQAIDKVVPVSSTKAAEMTKLLENIHRAVNIGLVNEMKVVADRMGIDIFEVVDAAATKPFGFTPYYPGPGLGGHCIPIDPFYLTWKAREYGLHTRFIELSGEVNKAMPEYVVSKLMDGLNERGKALKGSRVLVLGIAYKKNVDDMRESPSVEIMELIQAKGGIVSYSDPHVPSFPKMREHHFDLASEPLTAERLSRFDAVVLATDHDRFDYDLIHAHASLVVDSRGKYRAPSQKVIKA	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	112.63	gnl|BL_ORD_ID|894|hsp_num:0	842			6	1032	polymyxin B
BGC0000784.1|O-antigen_8 # 5306 # 5890 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.463	BGC0000784.1|O-antigen_8 	5306	5890	+	Loose	400	44.2838	vatB	42.0	3002841	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGGGGTTTTATCAGCACGATAGCGCAATTGTTGATGAAGGAGCTCAAATTGGAGACGGTTCTCGAATTTGGCACTTCGTGCATGTGTGTGCAGGGGCTAGAATTGGCAAGGAAGTTTCTCTAGGCCAAAATGTGTTTGTTGGAAATAAAGTATCCATTGGTGATCGATGTAAAATTCAGAACAACGTATCTGTCTATGACAATGTTACTCTAGAGGAAGGGGTCTTTTGTGGACCGAGTATGGTATTTACAAATGTCCATAATCCACGTTCGCTAATTGAGCGAAAAAGTGAGTACCTGAATACACTGGTGAAACGTGGCGCTACCTTGGGAGCCAACTGCACCATTGTCTGTGGGGTAACTATCGGTTCCTTTGCTTTTGTTGGGGCTGGAGCTGTAGTCACGTCAGATGTGCCATCATATGCGTTGATGGTAGGTGTTCCCGCACGACAAGTTGGTTGGATGAGCGAGTACGGTGAAAGACTTGATTTGCCGGTGAATGGAAAAGGTAAGGCTACTTGTCCACATACTGGGGATACGTATCGACTGTCTGCAGATGGACTGGTGAAGGAGTTGGTGGCGTGA	MGFYQHDSAIVDEGAQIGDGSRIWHFVHVCAGARIGKEVSLGQNVFVGNKVSIGDRCKIQNNVSVYDNVTLEEGVFCGPSMVFTNVHNPRSLIERKSEYLNTLVKRGATLGANCTIVCGVTIGSFAFVGAGAVVTSDVPSYALMVGVPARQVGWMSEYGERLDLPVNGKGKATCPHTGDTYRLSADGLVKELVA	MKYGPDPNSIYPHEEIKSVCFIKNTITNPNIIVGDYTYYSDVNGAEKFEEHVTHHYEFRGDKLVIGKFCAIAEGIEFIMNGANHRMNSITTYPFNIMGNGWEKATPSLEDLPFKGDTVVGNDVWIGQNVTVMPGIQIGDGAIVAANSVVTKDVPPYRIIGGNPSRIIKKRFEDELIDYLLQIKWWDWSAQKIFSNLETLCSSDLEKIKSIRD	91.51	gnl|BL_ORD_ID|1096|hsp_num:0	1189			345	495	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0000784.1|O-antigen_10 # 6966 # 8198 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.405	BGC0000784.1|O-antigen_10 	6966	8198	+	Loose	1900	29.261	acrB	30.23	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAGTATTCTCATACTTACAAATGCTTTCCCTTATTATCCTGGGGAGCAATTTATTGAAGATGAGATAGCATTTTGGGCTGAGAGCTCATTTTCCGAGGTGTATATTTTGCCCGCCACTTGCGGAAAAGATAGAAGATGGCTGCCTGAGAATATAACGCTCTCAACCCCGATTCAAGAAAAATCGAGATTGAATTTGATTTTTAGAGCGCTTATTTCCGCTGTCTTCATAAAAGAGATTCGATGTTTGATAAAAGCAAGGGAGTTCAGCTTTTTAAAATTATATTATGCATTAAAAGCGTCGGCATTGACCAAGTCATCTGAGTTGGCGTTGCGCCAATTCGTATCCAATAATGGAAAAATCGATGTCGTTTATTGTTATTGGAATGATGTACAAGCTTACGCTTCTTGTTTGCTGAAGCAGGAAGGGTTAATCGGTAAAGTAATCTCTAGAGCTCATGGGTTCGATCTTTACGAAGAGCGACGCGCGCATGGCTATATGCCTCTGAAGCGACAGTTTGTTGATTGTTTTGATGCCGTATTTCTTCTTTCCGAACAAGGCAGAAATTATTATCAAGAGCGCTATTCTGCAGCCGATGAAAAACTCAAGATTTCTAAGTTAGGTGTACCCATTCCCAAAGGTGGTTCAAAAGTAAGTGAGGAGGGACTCCATCTGGTCTCTCTTTCTTCATGTATTCCTATAAAAAGAATTGACAAAATCATTTCCACTGTGAGGCTTCTTGCCCTTGAACACCGCTCCATTAAAATAAAGTGGACCCACTTGGGTGGAGGAGCTTTGAAGCTTGATCTCGAGTCTCTAGCCAGGACGGAACTAGGAGAGCTTGAGAATGTAAGTTTTCACTTTATGGGAGAAGTCGAAAATAAAGAAGCGAAAGCTTTTTTCCTAAATAATGCTGTTGATTTCTTTATTAATGCAAGCGAGTCGGAAGGTGTGCCGGTTTCCATTATGGAAGCGATGAGTGCTGGCGTTCCTGCAATTGCTCCTTGTGTAGGTGGAATCAGATCTCTGATAGATAATAGTTGTGGGCGGTTGCTTTCTGAAAACCCTACTCCCGAAGAGTACTGTAGCTCAATTTCCAAACTCTATCTGGGAGGAGACAGGAAAACAATGCGGGAAACGGCACGTAAAAAAATAGAGAAAGATTTTAGTTCTGAGCAGAACTATAGGTCTTTTATAAAAGAAGTAGAATATTTAGTAGAAGAAAAATAA	MSSILILTNAFPYYPGEQFIEDEIAFWAESSFSEVYILPATCGKDRRWLPENITLSTPIQEKSRLNLIFRALISAVFIKEIRCLIKAREFSFLKLYYALKASALTKSSELALRQFVSNNGKIDVVYCYWNDVQAYASCLLKQEGLIGKVISRAHGFDLYEERRAHGYMPLKRQFVDCFDAVFLLSEQGRNYYQERYSAADEKLKISKLGVPIPKGGSKVSEEGLHLVSLSSCIPIKRIDKIISTVRLLALEHRSIKIKWTHLGGGALKLDLESLARTELGELENVSFHFMGEVENKEAKAFFLNNAVDFFINASESEGVPVSIMEAMSAGVPAIAPCVGGIRSLIDNSCGRLLSENPTPEEYCSSISKLYLGGDRKTMRETARKKIEKDFSSEQNYRSFIKEVEYLVEEK	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	39.08	gnl|BL_ORD_ID|1011|hsp_num:0	1104			93	222	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000784.1|O-antigen_11 # 8198 # 9625 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.422	BGC0000784.1|O-antigen_11 	8198	9625	+	Loose	900	28.8758	hmrM	19.81	3003953	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGGTTTCTCGGAAGATAGCGGTTTTTGCTATAGGCTCTATCGGGTCGGCTGTTCTTGGTCTGATAACGCTCCCTATAATTACTTGGTTTTATTCCGCTGAAGATGTTGGCCGGATTGCAATGCTTCAAGTTGCCTCAAACTTCTGTGTTCTCCTTTTTTGTCTAGGGTTGGATCAAGCCTATGTGCGTGAATATCACGAAGAAAAAAATCGCTCGGCATTATTGAAATCTTGTCTTTTCCCCGGGTTGTTTTTTTTGCTTTTGTCTTGTTCTTTTTTGTTTTTTTATGATGCATCGATACTTTCTGATTTTATGTACGAGAAAAGCGATGGTCTACTTGCCTATCTGACAATGCTTTGTTTTGTTTTTGCATTGGTTTCTCGCTTCCTCTCCCTGATTCTGAGAATGCAGGAAAGAGCTCTTGCGTTCTCTTTGACTCAGATATCGCCTAAAATTCTTTTTTTGATCGTCATTGCGTCATTTTTTGTTTTTTCCATACCGGCCTCTTTTGTAAGTTTATTAGTGGCGCAAGCAATATCTATGTTTACGATCATGTCTATTTTTGCTTGGAATACCCGTGGTGAATGGAGACCATGGAATGCCTATACGTTGTACAAGACACAGTTTCATGAGTTGTTGCGTTTCGGTCTACCATTAGTTGTGGGCGGAGTGGCGGCATGGGGACTGTATGTCATGGATAGACTCTTTTTGCGTGCCTTCTCTACCTTTTCAGAGTTGGGGATATATTCAGTAGCGGTGAGTATCGCAGCAGGTGCTGGTATTCTTGGAAACATTTTTACGACCATATGGTCTCCAACGGTCTTCAAATGGGCTGCCGAGGGGGTTGATGAAAAGAAAATTGATGAAATATCGGAGCATGTACTGGCGTGCGTTTTCTATATATTTATAATAAGTGGGCTGTTCTCTTGGATGGTTCCACTTTTTTTACCTGAAGCATATGCGCCCATACAGTACATGATAACAGTATGTGTGGCCTCTCCCTTACTTTATGCTCTCTCAGAGGCAACGGCGATCGGCATCAGCATTTCTCGCCGAACCGGTCTTTCTATGCTGTCTTCTATTTTAGCTGCGTTAACTAGCTTCGGTGGTAATTATCTGTTGGTTCCTCTCTATGGAGCAGCTGGTGCAGCGGTAGCTACTGCTGTTGCGTTTTGGGTTTTTCTATTCTGCCGAACTGAGTTTTCGTGTTCGGTGTGGCGTAAGATACCTAGGCTTAAGCTTTATATGGTTACCTCTTTCTGCACTTTGACAAGCTCATTGATTCTGCTCTCCGAAGAAAAAAATCAGGCTCTTATCTTGGTTTTCTGGGCATTACTTGGATTGAAAGGAGCTTTCCTTTTCCGAAAATCTATTGGGCTTCTTCTTTCGGTGCTTATTTCTCACTATAGGAAAAGAAAAACATGTTGA	MVSRKIAVFAIGSIGSAVLGLITLPIITWFYSAEDVGRIAMLQVASNFCVLLFCLGLDQAYVREYHEEKNRSALLKSCLFPGLFFLLLSCSFLFFYDASILSDFMYEKSDGLLAYLTMLCFVFALVSRFLSLILRMQERALAFSLTQISPKILFLIVIASFFVFSIPASFVSLLVAQAISMFTIMSIFAWNTRGEWRPWNAYTLYKTQFHELLRFGLPLVVGGVAAWGLYVMDRLFLRAFSTFSELGIYSVAVSIAAGAGILGNIFTTIWSPTVFKWAAEGVDEKKIDEISEHVLACVFYIFIISGLFSWMVPLFLPEAYAPIQYMITVCVASPLLYALSEATAIGISISRRTGLSMLSSILAALTSFGGNYLLVPLYGAAGAAVATAVAFWVFLFCRTEFSCSVWRKIPRLKLYMVTSFCTLTSSLILLSEEKNQALILVFWALLGLKGAFLFRKSIGLLLSVLISHYRKRKTC	MNFRLLSQYHTDIKKLIKISLPILLAQIAQNSMGLADTIMAGRVSSTDMAAISIGASIWMPLMFFGQGLLLALPPTISYLNGSGQHHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQYMQMESKMSDLARNYLHAMLWGLPAYLMLINFRCLNDGIEKTKPAMVITFLGLLINIPLNYIFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNTQERSLKVFSQLIEMPNPKTLKKLLRLGLPIAIAICCEVALYALTSLMLSPLGATIVASHQITLNTSSFIFMFPMSIGMATTILVGQALGAGSPQNAKKIGYAALLLGLTVTIVTALITIFFRYEIASIFVTDEIVIAMAANLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYTLGRTDWLVPHIDAKGFWIAFVVSLTFAAFLLSLRMKKMQAMNDNAILQRLEKLK	102.37	gnl|BL_ORD_ID|2186|hsp_num:0	2425			24	618	acriflavine; norfloxacin
BGC0000784.1|O-antigen_13 # 11110 # 12000 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.401	BGC0000784.1|O-antigen_13 	11110	12000	+	Loose	550	38.891	PmrF	23.76	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGGTGTAGATGTTTCAATTTTGATGCCGGTCTATAATGAAGTTTTGCATCTTGAAGAGGCTCTCCAAAGTATTTCTGAGCAGGGTGAAAAGCTTTCTATTGAGGTCGTCTGTGTTGATGATTTTTCTACGGATGGGACGTGGCAGTTGATGGAGCAGCTGCGGAATAAATATAATTTTCTCAAGTGCTATAAGAATGAAAAAAAAGGTAAGAACAATGCCTTCAATTTTGCCTATGAGAGGTCTAGTGGAGGTGTTGTGGTGTTGTTGGCTGGTGACGATAAACTTGTACCTAACACCTTGAGAGCGCGAGTAGATCCAGTACTGGATCAAGATGAGAACTTTATTACTCTCTGTAAATATAGAACTTTTTCAAAAACTAAGTACCTAGATGGAATGGTTTTTCCTAAGGATAGAGAGTTAGGTTCTCTTTCGGGGGGGACAATAGCTTTCAATAGAAGATTTGCTGAGAGAGTCTTTCCTATTCCGCCTGTTCTTGGAAATGAGGATATGTGGATTAAGTGTCACGCCACCTATGCTGAAGACGTGAATGTTATCCATGTTCCAGTTGTTTCTCTGTTATATCGTTTGCATGATAATAATTCTTTAAAGAGAGATGTTGGGTTTTCTAAAAAAAACGAAATGATTTCGAAGAGATCCATTGTTTATAGTGTTTATCTAGAGAGATACAGGGGAGAGCTCTCGGTAGCGGTCTCCGCTTCGTTGGCTAAGCTCGCTGCTTTAGAAACTCTTCGTGCAAATCGATCCATTCTCAGCATTCTCTTCTTCAAGAATATTCCTCTTGTCGATAAGCTTCGAGCTATTGTTTATGCTTCGCCGTTGCTCCATTGGATTCATATTAGGCTGTTAAGATGGACCTCAAGAACTTGA	MGVDVSILMPVYNEVLHLEEALQSISEQGEKLSIEVVCVDDFSTDGTWQLMEQLRNKYNFLKCYKNEKKGKNNAFNFAYERSSGGVVVLLAGDDKLVPNTLRARVDPVLDQDENFITLCKYRTFSKTKYLDGMVFPKDRELGSLSGGTIAFNRRFAERVFPIPPVLGNEDMWIKCHATYAEDVNVIHVPVVSLLYRLHDNNSLKRDVGFSKKNEMISKRSIVYSVYLERYRGELSVAVSASLAKLAALETLRANRSILSILFFKNIPLVDKLRAIVYASPLLHWIHIRLLRWTSRT	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	91.93	gnl|BL_ORD_ID|1937|hsp_num:0	2014			27	330	polymyxin B
BGC0000784.1|O-antigen_14 # 12065 # 12343 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.459	BGC0000784.1|O-antigen_14 	12065	12343	+	Loose	200	26.1794	vanH gene in vanO cluster	25.0	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGATTTTGAAGATCACATATATCTTGAATCGTTCGGACTTCATGGGAGATGCCAATGTACACTTGCTTGACCTCGCTCATGGGGGGCGGCGGGCTGGCCATGACGTTACAATTCTTGTAGGCAGGGATGGGGTCTTCTTTAAAAGTTTGAGAGAAAGAGGGATTTCTTGCTTTCCTTTGAAACATATAAAGAGAGACATTGAACTAGTATCTGATCCATTCGATACTTGGCTGCCCAAGGGTTATTGGGATAGTTGGGGCCGAGGCGAGTTGAGATAG	MILKITYILNRSDFMGDANVHLLDLAHGGRRAGHDVTILVGRDGVFFKSLRERGISCFPLKHIKRDIELVSDPFDTWLPKGYWDSWGRGELR	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	26.29	gnl|BL_ORD_ID|761|hsp_num:0	786			804	972	vancomycin
BGC0000784.1|O-antigen_15 # 12359 # 13324 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.481	BGC0000784.1|O-antigen_15 	12359	13324	+	Loose	875	25.409	mdtP	37.7	3003550	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACATTTTGGTTACTGGTGGTGCCGGCTTCATTGGAAGCAAGGTGGTTTCGGAGCTGCTGAAGCGGGATATGAATGTCCGAATCTCCTCAAGGAAGATGCAATCCATCGTTGGGGTTGATTGTGTGAAAGTCGACCTCCTCAACAGTGAGGTCGATCTCGACTTCCTGGTGTCCGACTGTACGGTTATTCTCAACTGCCTCGGAGAGCTTCAGGATGAGAGCAAGATGCATGCTCTTCACGTCGAGGCAACAGAACGGCTGATCATTGCTGCGAAAAGAAGTGCTCGCCAATCTGGTATGCCAGTGCATTGGGTCCAACTAAGCAGTGTGGGTGCATACGGTCCTGTTCTGGAAAAGGCCAACTCCGAGCGTATTGTCACGGAGGAAACCGCTTCTGCTCCGGTAGGAGTTTATGAATGCACCAAGACGATTGCCGATGAACTGGTGATGTCTTCCGTCGAAAATGGTGTTTTCAGCTATTCTATTTTGCGTCCGTCCAATGTATATGGTTCAGGAATGCCAAACGGGTCGTTGCGTCAATGGGCGCGATTGATCAAGGCGCACTGTTTTTTCTATGTGGGGCCCCCAGGATCAGTTTCTACCTATGTACATGTTGACGATGTTGTCGAGGCACTTCTGCTCTGCGCATTTGAGGAAAGAGCGAAGAATCAGATATTCAATATTTCCAATGATTGCACACAAGAGAGCCTAGTGGAGGCGATGGCAGGATTGCAGGGAGTCTCTCCACCTTTTTTGCGCTTCCCAGAAGCGTTGGCGAGAATGATCGCCTTCGTTTTTTCGGGGATAAAGATGTTTCCTCTGACATCATCTCGTATAGATTCCTTGGTGGCGCGCACTCATTACTCATGCAATAAGTTGAACCATATATTAGGTTATGTGCCTAGTCGTGATATAACAAAAGAAATATCTGAAGTTATTCTCGATAAGGAAGGCCGGCGTTGA	MNILVTGGAGFIGSKVVSELLKRDMNVRISSRKMQSIVGVDCVKVDLLNSEVDLDFLVSDCTVILNCLGELQDESKMHALHVEATERLIIAAKRSARQSGMPVHWVQLSSVGAYGPVLEKANSERIVTEETASAPVGVYECTKTIADELVMSSVENGVFSYSILRPSNVYGSGMPNGSLRQWARLIKAHCFFYVGPPGSVSTYVHVDDVVEALLLCAFEERAKNQIFNISNDCTQESLVEAMAGLQGVSPPFLRFPEALARMIAFVFSGIKMFPLTSSRIDSLVARTHYSCNKLNHILGYVPSRDITKEISEVILDKEGRR	MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAGPVVEKK	65.78	gnl|BL_ORD_ID|36|hsp_num:0	45			1182	1353	acriflavine; puromycin
BGC0000784.1|O-antigen_16 # 13354 # 14502 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.473	BGC0000784.1|O-antigen_16 	13354	14502	+	Loose	700	39.6614	LpsB	23.88	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGCGCATCGCCAGGGTCTCTACTGTGACTTTTTTTGTTGAGACCCAATTGAGAGCTCAAATTTCCGCACTTGCCCATGCGGGTGCCGAGATCACGATTGTTGCTAGTGAAAAAGAGCTTTCTAAAGATATTGATAATTGCCGTTATGCTTCTATTGTAATTCCAAGAAAAATTTCTCCGCTTAGCGATCTCCTGGCTTTGTATAAACTCTGGCGATTTTTTCGAAAAGAGCGCTTTGACATCGTTCACTCTACCACTCCAAAGGCAGGTTTGTTATGTGCGCTAGCAGGAAAGCTTGCCTTCGTGCCCATCCGTTTGCATACTTTTACGGGGCAGCCTTGGGTGGGTTTAAAAGGTTTGAAATATCTTCTTTCCAAGGGCAGTGACAAGCTTATAGCGCTTCTCAATACTCATTGCTATGCGGATAGTATTTCGCAGCGCAAATTCATCATCGATAGCGGTGTTGCAGATGATGACGATATCTCGGTTATTGGTGAAGGGTCGCTTGCCGGAATTGATCTGAAACGTTTCGCGGCTTCGCGGTATAGCTTGAATGAAAGAGTTTCTCTGAAAGCTTCCCTGGGTATCGGAAGAGCCTCGAAGACTCTGCTTTTTGTTGGGCGTCTTACTCAAGACAAGGGTGTTTTGGAGTTATTGGCGGCTTTTGAGAGCTTAGTCGGAAATCATGATGTTTTTCTTATGCTCCTTGGGCCGCATGAGATGAGCGAAGAAGAGCTTTTGGCCGGCTTTTCTAGTGATCTCAAGGAGCGACTTATTCTTTTGGGGTTTTCTGATGAGCCGGAAAAGTTCATGGCTATAGCGGATATGCTGCTCCTGCCTAGCTACAGGGAGGGTTTCGGTACTGTGGTGATCGAGGCCGCGGCCATGGGGGTGCCGACTATCGGTTCGGATATCTATGGTCTGAGCGATGCCATTGTCAATGGTGAGACAGGCCTGCTTGTGCCAGTGAAAAACTCTCAAGCGTTGGCTGCGGCAATCGATCAGCTATTAGGTGATGAGCGACTCTGCAAGGAACTGGGGGAAAAGGCTCGGATTCGAGTGGAGAAAGAATTTTCCAGTCAACGTATTAGCAATCTTTTGATTGGAGAATATACACGGTTGCTGGAGAAAGACAGGGGAGACTCATGA	MRIARVSTVTFFVETQLRAQISALAHAGAEITIVASEKELSKDIDNCRYASIVIPRKISPLSDLLALYKLWRFFRKERFDIVHSTTPKAGLLCALAGKLAFVPIRLHTFTGQPWVGLKGLKYLLSKGSDKLIALLNTHCYADSISQRKFIIDSGVADDDDISVIGEGSLAGIDLKRFAASRYSLNERVSLKASLGIGRASKTLLFVGRLTQDKGVLELLAAFESLVGNHDVFLMLLGPHEMSEEELLAGFSSDLKERLILLGFSDEPEKFMAIADMLLLPSYREGFGTVVIEAAAMGVPTIGSDIYGLSDAIVNGETGLLVPVKNSQALAAAIDQLLGDERLCKELGEKARIRVEKEFSSQRISNLLIGEYTRLLEKDRGDS	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	104.37	gnl|BL_ORD_ID|2781|hsp_num:0	3793			582	984	colistin A; colistin B; defensin
BGC0000784.1|O-antigen_17 # 14499 # 15458 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.510	BGC0000784.1|O-antigen_17 	14499	15458	+	Loose	1200	42.743	arnA	25.0	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGCAGAATCCTGGTGACAGGGGCCTCAGGTTTTGTTGGAAGGGCTTTGTCGGAGCAGTTGCAGCGTCTGGGGCATGGAGTCGTTGCCGCTGCACGAAGCACATCCTCTCGCATTCCTTCTTCTGTACGGTCTGTATTGACTGGTGACCTGTGTCCCGATACTGACTGGTCCGAGGCCTTGCAGGCGGTAGATATCGTTATTCATGCCGCGGCGCGCGTCCATGTGATGAATGAAACGCTTGCCGATCCACTTCAGGAGTTCCGCAAGGTGAATGTGGAGGCAACCTTGAACTTGGCGCGACAGGCTGCGAGCAAGGGGGTACGGCGCTTCATATTTATCAGTTCAATAAAGGTCAATGGAGAAGCTACAGAGGATGGGCGTCCATACAGAGCCGATGACGAACCCCGGCCGATTGACCCCTATGGCCTGTCTAAGCTAGAGGCGGAGAGAGGTCTTCTGGATCTGGCAGCAAGAACTGGAATCGAGGTGGTTATAATTCGCCCGGTCTTGGTTTATGGTCCAGGCGTCAAAGCCAATTTTCTCAACATGATGAAGGTTATTAATAAGAGAATTCCGCTTCCCTTCCTTCTGGTTGACAATCGAAGAAGCTTGGTGGCGTTGACCAATCTTGTCGATTTGATCACCTCCTGCCTTGAGCACCCTTCGGCCGCGAATCAAGTATTTTTGGTAAGCGACGATGAAGATCTTTCCACGAGTGAACTTTTAAAACGCATGGGGATTGCACTGGGTGCGCCTGCCCGGCTGCTTCCTGTGCCTGTTTTTCTTATGAAGTTTATAGCAAGAATGCTTGGTAAGGGTGCTTTCTCCCAGCGATTGCTTGGGTCTTTGCAGGTTGATATAAGCAAGACAAAAGAACTTTTGGCTTGGCATCCACCTTTGAACGTCGATGAGGCTTTGAAGGAGACGGCGCGCCACTTTCTGGATTCTAAAGAATGA	MSRILVTGASGFVGRALSEQLQRLGHGVVAAARSTSSRIPSSVRSVLTGDLCPDTDWSEALQAVDIVIHAAARVHVMNETLADPLQEFRKVNVEATLNLARQAASKGVRRFIFISSIKVNGEATEDGRPYRADDEPRPIDPYGLSKLEAERGLLDLAARTGIEVVIIRPVLVYGPGVKANFLNMMKVINKRIPLPFLLVDNRRSLVALTNLVDLITSCLEHPSAANQVFLVSDDEDLSTSELLKRMGIALGAPARLLPVPVFLMKFIARMLGKGAFSQRLLGSLQVDISKTKELLAWHPPLNVDEALKETARHFLDSKE	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	48.19	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1491	polymyxin B
BGC0000784.1|O-antigen_19 # 16611 # 17453 # 1 # ID=1_19;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.633	BGC0000784.1|O-antigen_19 	16611	17453	+	Loose	400	26.5646	vanR gene in vanN cluster	30.19	3002929	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGATAGATGGTTTGCGTGTTCGACTGCTGGGGCTGCCGCGTCGTTATAAAAGGATCTTGCAGGTCCTTGCCGACGTAGCGCTGGTCTGGCTCTCCCTTTGGTTGGCATTCTTGGTGCGGTTGGGCACGGAAGACATGATCAGCCCCTTCGAGGGCCATGCCTGGCTGTTCATCGCCGCCCCGTTGGTGGCCATTCCCCTGTTCATCCGCTTCGGCATGTACCGGGCGGTGATGCGCTACCTGGGCAACGACGCCCTTATCGCGATCGCCAAGGCCGTCACCATATCCGCGCTGGTCCTGTCGTTGCTGGTCTACTGGTACCGCTCCCCGCCGGCGGTGGTGCCGCGTTCCCTGGTGTTCAACTACTGGTGGTTGAGCATGCTGCTGATCGGCGGCTTGCGTCTGGCCATGCGCCAGTATTTCATGGGCGACTGGTACTCTGCTGTGCAGTCGGTACCATTTCTCAACCGCCAGGATGGCCTGCCCAGGGTGGCTATCTATGGCGCGGGGGCGGCCGGCAACCAGTTGGTTGCGGCATTGCGTCTCGGTCGGGCGATGCGTCCGGTGGCGTTCATCGATGATGACAAGCAGATCGCCAACCGGGTCATCGCCGGTCTGCGGGTCTATACCGCCAAGCATATCCGCCAGATGATCGACGAGACGGGCGCGCAGGAGGTTCTCCTGGCGATTCCTTCCGCCACTCGGGCCCGGCGCCGAGAGATTCTCGAGTCCCTGGAGCCGTTCCCGCTGCACGTGCGCAGCATGCCCGGCTTCATGGACCTGGCCAGCGGCCGGGTCAAGGTGGACGACCTGCAGGAGGTGGACATCGCTGACCTGCTGGGG	MIDGLRVRLLGLPRRYKRILQVLADVALVWLSLWLAFLVRLGTEDMISPFEGHAWLFIAAPLVAIPLFIRFGMYRAVMRYLGNDALIAIAKAVTISALVLSLLVYWYRSPPAVVPRSLVFNYWWLSMLLIGGLRLAMRQYFMGDWYSAVQSVPFLNRQDGLPRVAIYGAGAAGNQLVAALRLGRAMRPVAFIDDDKQIANRVIAGLRVYTAKHIRQMIDETGAQEVLLAIPSATRARRREILESLEPFPLHVRSMPGFMDLASGRVKVDDLQEVDIADLLG	MDTIVIVDDEKEIANLMTTFLENEGFKVMTFYSGKEALDYIDQNGASLAILDVMLPDLDGFQILQHIRQTFFFPVLMLTAKGENLDKITGLTLGADDYITKPFNPLEVVARVKTQLRRTQRYDQPSHSQSDEEFTKEGLVLKKNSHQVFLFDQEVLITPLEFKILLYLFEHQGTVVSSETLFEEVWQEKYLDNNNTVMAHIARLREKLGEKPRKPKYIKTVWGVGYIIEK	122.17	gnl|BL_ORD_ID|4738|hsp_num:0	1219			0	159	vancomycin
